Zenlabs Ethica (BSE 530697)₹25.60+0.39%Diversified Commercial Services
In the Mar 2026 quarter (standalone), Zenlabs Ethica reported sales of ₹10.56 Cr, down 18.6% from Mar 2025, and net profit of ₹0 Cr, down 100.0% year on year. For the year to Mar 2026, sales were ₹46.83 Cr and net profit −₹1.93 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.54 | 14.03 | 15.57 | 15.31 | 12.35 | 13.34 | 12.71 | 12.97 | 11.47 | 12.41 | 12.41 | 10.56 |
| Expenses | 13.06 | 13.64 | 14.92 | 14.60 | 11.76 | 12.74 | 12.05 | 12.35 | 10.94 | 12.00 | 11.93 | 10.32 |
| Operating Profit | 0.52 | 0.43 | 0.68 | 0.75 | 0.61 | 0.61 | 0.67 | 0.65 | 0.54 | 0.44 | 0.51 | 0.26 |
| OPM % | 3.9% | 3.1% | 4.4% | 5.0% | 5.0% | 4.7% | 5.4% | 5.1% | 4.8% | 3.6% | 4.2% | 2.6% |
| Other Income | 0.06 | 0.23 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.07 | −2.09 | 0.13 |
| Interest | 0.15 | 0.20 | 0.21 | 0.24 | 0.22 | 0.22 | 0.23 | 0.22 | 0.20 | 0.18 | 0.22 | 0.17 |
| Depreciation | 0.33 | 0.33 | 0.33 | 0.34 | 0.33 | 0.32 | 0.33 | 0.32 | 0.30 | 0.25 | 0.24 | 0.15 |
| Profit before tax | 0.09 | 0.12 | 0.14 | 0.19 | 0.06 | 0.07 | 0.11 | 0.15 | 0.04 | 0.07 | −2.01 | 0.06 |
| Tax % | 30.0% | 30.8% | 26.7% | 25.0% | 42.9% | 25.0% | 33.3% | 43.8% | 20.0% | 50.0% | 0.0% | 114.3% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.01 | 0.00 |
| Net Profit | 0.06 | 0.08 | 0.10 | 0.14 | 0.03 | 0.04 | 0.08 | 0.08 | 0.02 | 0.03 | −2.00 | 0.00 |
| EPS (Rs) | 0.10 | 0.13 | 0.16 | 0.22 | 0.05 | 0.07 | 0.13 | 0.13 | 0.04 | 0.05 | −3.08 | 0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.07 | 78.58 | 69.70 | 65.27 | 58.43 | 56.58 | 69.01 | 66.80 | 58.47 | 51.34 | 46.83 | 46.85 |
| Expenses | 14.92 | 77.43 | 68.14 | 63.41 | 59.32 | 54.97 | 66.81 | 64.04 | 56.25 | 48.91 | 45.16 | 45.19 |
| Operating Profit | 0.19 | 1.44 | 1.84 | 2.08 | −0.69 | 1.74 | 2.38 | 2.90 | 2.40 | 2.57 | 1.78 | 1.75 |
| OPM % | 1.3% | 1.9% | 2.7% | 3.2% | −1.2% | 3.1% | 3.5% | 4.4% | 4.1% | 5.0% | 3.8% | 3.7% |
| Other Income | −0.04 | 0.09 | 0.11 | 0.11 | 0.06 | 0.12 | 0.10 | −0.46 | 0.31 | 0.05 | −1.91 | −1.89 |
| Interest | 0.01 | 0.09 | 0.08 | 0.06 | 0.22 | 0.28 | 0.36 | 0.52 | 0.82 | 0.92 | 0.80 | 0.77 |
| Depreciation | 0.07 | 0.21 | 0.21 | 0.24 | 0.30 | 0.72 | 0.90 | 1.26 | 1.30 | 1.27 | 0.90 | 0.94 |
| Profit before tax | 0.08 | 1.22 | 1.65 | 1.88 | −1.16 | 0.85 | 1.21 | 0.67 | 0.58 | 0.42 | −1.80 | −1.84 |
| Tax % | −88.8% | 22.0% | 29.6% | 32.9% | −36.7% | 10.5% | 36.1% | 26.5% | 27.1% | 37.3% | 6.7% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.01 | −2.01 |
| Net Profit | 0.16 | 0.94 | 1.15 | 1.25 | −0.72 | 0.76 | 0.77 | 0.48 | 0.41 | 0.26 | −1.93 | −1.95 |
| EPS (Rs) | 0.25 | 1.45 | 1.77 | 1.93 | −1.11 | 1.17 | 1.19 | 0.74 | 0.64 | 0.40 | −2.97 | −2.99 |
| Dividend payout % | 0.0% | 16.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 33.2% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.62 | 6.22 | 6.22 | 6.21 | 6.53 | 6.53 | 6.50 | 6.52 | 6.53 | 6.51 | 6.49 | 6.50 |
| Reserves | −1.64 | −1.40 | −0.42 | 0.80 | 1.76 | 0.89 | 2.04 | 2.81 | 3.18 | 3.61 | 3.91 | 1.99 |
| Borrowings | 0.00 | 1.08 | 0.95 | 0.84 | 0.59 | 0.72 | 2.59 | 3.89 | 5.84 | 14.81 | 12.66 | 10.94 |
| Other Liabilities | 1.76 | 24.37 | 26.51 | 21.85 | 25.89 | 25.74 | 20.94 | 24.54 | 27.82 | 15.21 | 17.40 | 17.63 |
| Total Liabilities | 3.74 | 30.27 | 33.26 | 29.70 | 34.77 | 33.88 | 32.07 | 37.76 | 43.37 | 40.14 | 40.46 | 37.06 |
| Fixed Assets | 0.07 | 1.69 | 1.51 | 1.34 | 1.37 | 1.13 | 3.52 | 3.54 | 5.04 | 3.71 | 2.30 | 1.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 1.24 | 0.94 | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 | 0.00 |
| Other Assets | 3.67 | 27.34 | 30.81 | 27.67 | 32.71 | 32.06 | 27.86 | 33.53 | 37.64 | 35.74 | 37.47 | 35.18 |
| Inventories | 0.00 | 8.21 | 6.16 | 1.75 | 4.46 | 4.61 | 5.19 | 8.65 | 11.38 | 12.01 | 13.11 | 15.03 |
| Trade receivables | 0.47 | 16.45 | 23.20 | 24.17 | 24.94 | 22.21 | 18.85 | 20.71 | 21.66 | 20.69 | 19.50 | 15.68 |
| Cash & equivalents | 0.03 | 2.50 | 1.15 | 1.24 | 1.68 | 2.10 | 1.71 | 1.52 | 1.65 | 0.94 | 1.81 | 2.92 |
| Total Assets | 3.74 | 30.27 | 33.26 | 29.70 | 34.77 | 33.88 | 32.07 | 37.76 | 43.37 | 40.14 | 40.46 | 37.06 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.03 | 0.93 | −1.07 | 0.37 | 0.81 | 0.46 | −8.43 | −0.39 | 1.53 | −9.09 | 3.84 | 4.07 |
| Cash from investing activity | 0.00 | −1.70 | −0.03 | −0.04 | −0.23 | 0.02 | 0.16 | 0.00 | −1.48 | 0.12 | 0.15 | 0.00 |
| Cash from financing activity | 0.00 | 3.24 | −0.28 | −0.24 | −0.15 | −0.04 | −0.53 | 0.32 | 0.07 | 8.27 | −3.09 | −2.96 |
| Net cash flow | 0.01 | 2.46 | −1.34 | 0.08 | 0.43 | 0.42 | −8.77 | −0.06 | 0.10 | −0.70 | 0.87 | 1.10 |
| Capex | 0.00 | 1.68 | 0.01 | 0.02 | 0.38 | 0.04 | 0.00 | 0.02 | 1.54 | 0.01 | 0.01 | 0.00 |
| Free cash flow | 0.01 | −0.76 | −1.07 | 0.32 | 0.50 | 0.41 | −8.34 | −0.40 | −0.02 | −9.07 | 3.97 | 4.07 |
| CFO / OP % | −40.0% | 460.1% | −72.9% | 19.0% | 38.0% | −64.0% | −474.9% | −11.0% | 62.1% | −371.0% | 157.1% | 234.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | 399 | 109 | 127 | 140 | 140 | 123 | 111 | 119 | 130 | 140 | 123 |
| Inventory days | — | 249 | 33 | 10 | 30 | 33 | 39 | 55 | 77 | 99 | 127 | 160 |
| Days payable | — | 664 | 135 | 125 | 160 | 164 | 149 | 140 | 173 | 100 | 139 | 164 |
| Cash conversion cycle | — | −18 | 6 | 12 | 9 | 7 | 12 | 24 | 22 | 128 | 127 | 118 |
| Working capital days | — | 5 | 13 | 22 | 28 | 24 | 28 | 35 | 35 | 47 | 53 | 39 |
| ROCE % | −3.0% | 10.0% | 21.1% | 24.0% | 24.1% | −11.0% | 12.0% | 13.1% | 12.5% | 7.0% | 5.7% | 5.1% |
For the Mar 2026 quarter, Zenlabs Ethica reported sales of ₹10.56 Cr, down 18.6% year on year and net profit of ₹0 Cr, down 100.0% year on year. The operating margin was 2.6%.
Zenlabs Ethica's sales for the year to Mar 2026 were ₹46.83 Cr; over the last twelve months they were ₹46.85 Cr.
Net profit for the year to Mar 2026 was −₹1.93 Cr, and −₹1.95 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.99.
Zenlabs Ethica reported borrowings of ₹10.94 Cr at Mar 2026, against cash and equivalents of ₹2.92 Cr.
Cash from operations was ₹4.07 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹4.07 Cr.